Cyclopharm Limited announced a private placement of 100,000 common shares at an issue price of AUD 2.18 for the gross proceeds of AUD 218,000 on April 17, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 AUD | -3.03% | -6.43% | -16.88% |
Mar. 19 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
Mar. 18 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.88% | 104M | |
+12.15% | 228B | |
+14.90% | 196B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 65.88B | |
+16.92% | 54.3B | |
+6.33% | 52.39B | |
+10.93% | 45.22B | |
+5.87% | 37.12B |
- Stock Market
- Equities
- CYC Stock
- News Cyclopharm Limited
- Cyclopharm Limited announced that it expects to receive AUD 0.218 million in funding